Spike Health Attends Online Exhibition
Release time:
2020-07-15
Due to the impact of the epidemic, the exhibition in the first half of 2020 was postponed. In early March, the Food Business Network and Gade Chemical Network launched an online exhibition. As an established member, Peak Health set up booths in the Food Business Network's Food Raw Ingredients Hall and Gade Chemical Network's Natural Raw Materials Hall, and focused on promoting new cranberry juice powder and broken Ganoderma spore oil during the online exhibition.
21FOOD Online Exhibition and Gade Online Exhibition are online public welfare exhibition projects initiated by Food Business Network and Gade Chemical Network, respectively, and the original intention of the exhibition is to help food enterprises and chemical enterprises fight the epidemic and tide over the difficulties. At the same time, it is also hoped that this digital exhibition model of "moving offline exhibitions to online" can be promoted, so that the majority of food and food-related enterprises can visit exhibitions and talk about business anytime and anywhere without being limited by time and space. Compared with traditional exhibitions, online exhibitions are more convenient and efficient. Enterprises can participate in and watch the exhibition through one mobile phone and one computer, so as to realize investment promotion, product selection, technical exchange and other business needs. At the exhibition, exhibitors and visitors from all over the country can directly "face-to-face" communication, and negotiate business through different forms such as online interactive communication, video and new product release special docking. At the same time, the online exhibition has also opened a series of functions for buyers and sellers, such as online business card exchange and online transaction, to help enterprises communicate and cooperate efficiently through technical empowerment.
The 21FOOD Online Exhibition, Additives and Ingredients Special Exhibition, which opened on March 6, is the first concentrated exhibition of the "21FOOD Online Exhibition" series. Gade's online exhibition is divided into 6 professional exhibition halls, including pharmaceutical raw materials exhibition hall, biological medicine exhibition hall, contract customization exhibition hall, natural extract exhibition hall, intermediate and fine chemical exhibition hall, laboratory instrument and equipment exhibition hall. The number of professional visitors to the exhibition exceeded 150000. This online exhibition will end at the end of March, during which viewers can leave messages through QQ online consultation and message area.
During the on-line exhibition, Jianfeng Health continuously received customer consultation, negotiation and communication, and collected effective customer resources. Among them, the exhibits in the new product area, such as cranberry powder and ganoderma lucidum spore oil, have received more than 80000 praises up to the time of publication. (Cheng guo)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page